molecular subtype
Showing 51 - 75 of 5,769
Thyroid Carcinoma
Recruiting
- Differentiated Thyroid Carcinoma
- Medullary Thyroid Carcinoma
- Immunohistochemistry (IHC)
- +2 more
-
L'Hospitalet De Llobregat, Barcelona, Spain
- +11 more
Mar 22, 2022
Renal Cell Carcinoma Trial in Chapel Hill (PET/MR)
Recruiting
- Renal Cell Carcinoma
- PET/MR
-
Chapel Hill, North CarolinaUNC- Chapel Hill
Oct 26, 2021
COPD, Lung Non-Small Cell Carcinoma, Pneumonia Trial in Buffalo (Quality-of-Life Assessment, Questionnaire Administration,
Recruiting
- Chronic Obstructive Pulmonary Disease
- +7 more
- Quality-of-Life Assessment
- +2 more
-
Buffalo, New YorkRoswell Park Cancer Institute
Oct 20, 2022
Searching for Novel Germline Mutations in Lobular Breast Cancer
Recruiting
- Lobular Breast Carcinoma
- +3 more
- Illumina panel
-
Milan, ItalyEuropean Institute of Oncology
Sep 12, 2022
Cerebral Thrombi in Determining Prognosis and Etiology of
Recruiting
- Ischemic Stroke
- Thrombi and blood analyses
-
Fort-de-France, France
- +2 more
Jan 21, 2023
Clinical Resistance to Chemotherapy in Triple Negative Breast
Completed
- Triple Negative Breast Cancer
- Needle core biopsies
- Needle core biopsies of metastatic lesion
-
Chicago, Illinois
- +7 more
May 27, 2022
Esophageal Cancer Trial in Tainan, Taipei
Recruiting
- Esophageal Cancer
-
Tainan, Taiwan
- +1 more
Apr 5, 2022
Molecular Profiling in Prostate Cancer
Recruiting
- Prostate Cancer Metastatic
- +4 more
- Tumor molecular profiling
-
Athens, GreeceHellenic Cooperative Oncology Group
Mar 15, 2022
Castration-resistant Prostate Cancer, Prostate Cancer Metastatic Trial in Tianjin (Luminal type-1, Luminal type-2,
Recruiting
- Castration-resistant Prostate Cancer
- Prostate Cancer Metastatic
- Luminal type-1
- +5 more
-
Tianjin, ChinaTianjin Medical Unversity Second Hospital
Oct 4, 2018
Personalised Medicine Tool for Multiple Myeloma That Predicts
Active, not recruiting
- Multiple Myeloma
- Gene Expression Profiling
-
Turin, ItalyUniversity of Turin
Mar 24, 2022
Primary Aldosteronism in Blacks
Recruiting
- Adrenal Gland Neoplasm
- +4 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Aug 11, 2022
Gene Expression in Chronic Venous Leg Ulcers
Recruiting
- Genetic Predisposition to Disease
- +2 more
- Genetic assessment
-
Catanzaro, ItalyUniversity Magna Graecia of Catanzaro
Nov 14, 2021
ArTificial inTelligence-based RAdiogenomics in Colon Tumors
Recruiting
- Colon Cancer Stage II
- Colon Cancer Stage III
-
Roma, RM, ItalyAOU Sant'Andrea
Oct 24, 2023
Breast Cancer Trial in Taipei City (PET/MR)
Recruiting
- Breast Cancer
- PET/MR
-
Taipei City, TaiwanDepartment of Radiology,Taipei Veterans General Hospital
Jul 18, 2022
Peripheral Serotonin and Albinism
Not yet recruiting
- Oculocutaneous Albinism
- Dosage of serotonin and metabolites
- Blood parameters
-
Paris, FranceHôpital Necker-Enfants Malades
Nov 14, 2023
Helicobacter Pylori Local Prevalence and Antibiotic Resistance
Recruiting
- Helicobacter Pylori Infection
- +5 more
-
Munich, GermanyDepartment of Medicine II, University Hospital of Munich
Sep 27, 2022
Irritable Bowel Syndrome Trial in Germany, Italy (Colilen IBS, Placebo)
Recruiting
- Irritable Bowel Syndrome
- Colilen IBS
- Placebo
-
Karlsruhe, Germany
- +6 more
Jun 28, 2022
Breast Cancer Trial in Seoul
Not yet recruiting
- Breast Cancer
-
Seoul, Korea, Republic ofSeoul National University Hospital
Mar 23, 2022
Molecular Classification of Relapsed/Refractory Diffuse Large
Completed
- Lymphoma, Large B-Cell, Diffuse
- Gene Expression Profiling
- Gene expression profile
-
Shanghai, Shanghai, ChinaYian Zhang
Mar 31, 2022
COGNITION: Genomics-Guided Precision Oncology in Early High-Risk
Recruiting
- Early-Stage Breast Cancer
- Neoadjuvant Therapy
- Genomic Profiling / Sequencing
-
Berlin, Germany
- +4 more
Jun 19, 2023
Neuroendocrine Neoplasia's (NENs), Gastroenteropancreatic Neuroendocrine Tumour (GEP-NET) Trial in Basel (161Tb-DOTA-LM3,
Not yet recruiting
- Neuroendocrine Neoplasia's (NENs)
- Gastroenteropancreatic Neuroendocrine Tumour (GEP-NET)
-
Basel, SwitzerlandDivision of Nuclear Medicine, University Hospital Basel
Apr 27, 2022